miR-200c-3p upregulation and ACE2 downregulation via bacterial LPS and LTA as interesting aspects for COVID-19 treatment and immunity
Mol Biol Rep
.
2021 Jul;48(7):5809-5810.
doi: 10.1007/s11033-021-06378-x.
Epub 2021 May 3.
Authors
Saber Soltani
1
2
,
Milad Zandi
3
4
Affiliations
1
Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
[email protected]
.
2
Research Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, Iran.
[email protected]
.
3
Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
4
Research Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, Iran.
PMID:
33939073
PMCID:
PMC8091633
DOI:
10.1007/s11033-021-06378-x
No abstract available
Publication types
Comment
MeSH terms
COVID-19 Drug Treatment*
Down-Regulation
Humans
Lipopolysaccharides
MicroRNAs* / genetics
Peptidyl-Dipeptidase A
SARS-CoV-2
Up-Regulation
Substances
Lipopolysaccharides
MicroRNAs
Peptidyl-Dipeptidase A